Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients

C. Beck-Sague, S. W. Dooley, M. D. Hutton, J. Otten, A. Breeden, J. T. Crawford, A. E. Pitchenik, C. Woodley, G. Cauthen and W. R. Jarvis
Hospital Infections Program, Centers for Disease Control, Atlanta, GA 30333.

OBJECTIVE--To describe transmission of multidrug-resistant (MDR) Mycobacterium tuberculosis infection among patients and health care workers (HCWs) in a ward and clinic for human immunodeficiency virus (HIV)-infected patients in a hospital, four studies were conducted. METHODS--Case patients and control patients were persons who had been treated in the HIV ward or clinic, whose clinical course was consistent with tuberculosis and who had at least one positive culture for M tuberculosis between January 1, 1988, and January 31, 1990, resistant to at least isoniazid and rifampin (case patients), or whose isolates were susceptible to all drugs tested (control patients). In the first study, case patients and control patients were compared to identify risk factors for MDR tuberculosis. In the second study, inpatient and outpatient days of MDR tuberculosis case patients were compared to determine whether acid-fast bacillus (AFB) smear-positivity or aerosolized pentamidine use was associated with higher numbers of subsequent MDR tuberculosis cases among exposed patients. In the third study, restriction fragment length polymorphism analysis was performed on available MDR and sensitive M tuberculosis isolates. In the fourth study, skin test conversion rates among HCWs in the HIV ward and clinic were compared with those of HCWs in another ward, and the strength of the associations between skin test conversions among HCWs on the HIV ward and the number of person-days that AFB smear-positive case patients and control patients were on this ward was estimated. RESULTS--Case patients were more likely than control patients to have been exposed on the HIV ward or clinic to an AFB smear-positive case patient (P less than .001). Inpatient and outpatient days of MDR tuberculosis case patients were associated with more subsequent cases of MDR tuberculosis if exposing case patients were smear-positive or if they received aerosolized pentamidine (P less than or equal to .01). Of 13 MDR isolates, all had one of two restriction fragment length polymorphism patterns; 10 sensitive isolates had restriction fragment length polymorphism patterns that were different from each other. The HCW skin test conversion rate was higher on the HIV ward and clinic than on the comparison ward (P less than .01). The risk of occupational acquisition of infection increased in direct proportion to the number of person-days that AFB smear-positive case patients were on the HIV ward (r = .75; P = .005), but did not increase in proportion to the number of person-days that AFB smear-positive control patients were there (r = -.36; P = NS). After isolation measures for AFB smear-positive tuberculosis patients were improved, MDR tuberculosis cases decreased to seven of 214 tuberculosis patients. CONCLUSIONS--Nosocomial transmission of MDR M tuberculosis infection to patients and HCWs occurred on the HIV ward and clinic. Infectiousness of MDR tuberculosis case patients was associated with AFB sputum-smear positivity. Case patients with MDR tuberculosis created a greater risk of skin test conversion for HCWs on the HIV ward than drug-susceptible control patients.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling Tuberculosis in the United States
Am. J. Respir. Crit. Care Med. 2005;172:1169-1227.
FULL TEXT  

Multidrug Resistance Among Persons With Tuberculosis in California, 1994-2003
Granich et al.
JAMA 2005;293:2732-2739.
ABSTRACT | FULL TEXT  

Prevention of Infection Due to Pneumocystis spp. in Human Immunodeficiency Virus-Negative Immunocompromised Patients
Rodriguez and Fishman
Clin. Microbiol. Rev. 2004;17:770-782.
ABSTRACT | FULL TEXT  

Genotypic and Phenotypic Characterization of Drug-Resistant Mycobacterium tuberculosis Isolates from Rural Districts of the Western Cape Province of South Africa
Streicher et al.
J. Clin. Microbiol. 2004;42:891-894.
ABSTRACT | FULL TEXT  

Multidrug-resistant tuberculosis: eight years of surveillance in France
Robert et al.
Eur Respir J 2003;22:833-837.
ABSTRACT | FULL TEXT  

Molecular Epidemiology of Tuberculosis in a Rural Area of High Prevalence in South India: Implications for Disease Control and Prevention
Narayanan et al.
J. Clin. Microbiol. 2002;40:4785-4788.
ABSTRACT | FULL TEXT  

Whole-Genome Comparison of Mycobacterium tuberculosis Clinical and Laboratory Strains
Fleischmann et al.
J. Bacteriol. 2002;184:5479-5490.
ABSTRACT | FULL TEXT  

The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees
Moreno et al.
Arch Intern Med 2001;161:1760-1765.
ABSTRACT | FULL TEXT  

Molecular and Conventional Epidemiology of Mycobacterium tuberculosis in Botswana: a Population-Based Prospective Study of 301 Pulmonary Tuberculosis Patients
Lockman et al.
J. Clin. Microbiol. 2001;39:1042-1047.
ABSTRACT | FULL TEXT  

Is the detection of Mycobacterium tuberculosis DNA by ligase chain reaction worth the cost: experiences from an inner London teaching hospital
Shetty et al.
J. Clin. Pathol. 2000;53:924-928.
ABSTRACT | FULL TEXT  

Hospital Ventilation and Risk for Tuberculous Infection in Canadian Health Care Workers
Menzies et al.
ANN INTERN MED 2000;133:779-789.
ABSTRACT | FULL TEXT  

Evaluation of Clinical Parameters to Predict Mycobacterium tuberculosis in Inpatients
Wisnivesky et al.
Arch Intern Med 2000;160:2471-2476.
ABSTRACT | FULL TEXT  

How long are TB patients infectious?
Schwartzman and Menzies
CMAJ 2000;163:157-158.
FULL TEXT  

Phthisiology at the Dawn of the New Century
Lauzardo and Ashkin
Chest 2000;117:1455-1473.
ABSTRACT | FULL TEXT  

Nosocomial Tuberculosis Prevention Measures Among Two Groups of US Hospitals, 1992 to 1996
Manangan et al.
Chest 2000;117:380-384.
ABSTRACT | FULL TEXT  

Transmission Dynamics of Tuberculosis in a High-Incidence Country: Prospective Analysis by PCR DNA Fingerprinting
Haas et al.
J. Clin. Microbiol. 1999;37:3975-3979.
ABSTRACT | FULL TEXT  

Tuberculosis: 11. Nosocomial disease
Schwartzman and Menzies
CMAJ 1999;161:1271-1277.
FULL TEXT  

"Won't Get Fooled Again" (by Tuberculosis)
Ashkin et al.
Chest 1999;116:856-857.
FULL TEXT  

Comparison of Methods Based on Different Molecular Epidemiological Markers for Typing of Mycobacterium tuberculosis Complex Strains: Interlaboratory Study of Discriminatory Power and Reproducibility
Kremer et al.
J. Clin. Microbiol. 1999;37:2607-2618.
ABSTRACT | FULL TEXT  

Outcome of Multi-drug-resistant Tuberculosis in France . A Nationwide Case-Control Study
FLAMENT-SAILLOUR et al.
Am. J. Respir. Crit. Care Med. 1999;160:587-593.
ABSTRACT | FULL TEXT  

A Molecular Epidemiologic Analysis of Tuberculosis Trends in San Francisco, 1991-1997
Jasmer et al.
ANN INTERN MED 1999;130:971-978.
ABSTRACT | FULL TEXT  

Molecular Evidence for Heterogeneity of the Multiple-Drug-Resistant Mycobacterium tuberculosis Population in Scotland (1990 to 1997)
Fang et al.
J. Clin. Microbiol. 1999;37:998-1003.
ABSTRACT | FULL TEXT  

Foci of Tuberculosis Transmission in Central Los Angeles
BARNES et al.
Am. J. Respir. Crit. Care Med. 1999;159:1081-1086.
ABSTRACT | FULL TEXT  

Delays in the Suspicion and Treatment of Tuberculosis among Hospitalized Patients
Rao et al.
ANN INTERN MED 1999;130:404-411.
ABSTRACT | FULL TEXT  

Carrots, sticks and tuberculosis
COKER
Thorax 1999;54:95-96.
FULL TEXT  

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus"
Farmer and Kim
BMJ 1998;317:671-674.
FULL TEXT  

Are US Hospitals Making Progress in Implementing Guidelines for Prevention of Mycobacterium tuberculosis Transmission?
Manangan et al.
Arch Intern Med 1998;158:1440-1444.
ABSTRACT | FULL TEXT  

Evaluation of four DNA typing techniques in epidemiological investigations of bovine tuberculosis [In Process Citation]
Cousins et al.
J. Clin. Microbiol. 1998;36:168-178.
ABSTRACT | FULL TEXT  

Tuberculosis in the hospice a cause for concern?
McKeogh
Palliat Med 1997;11:469-474.
ABSTRACT  

Molecular diagnostics of infectious diseases
Tang et al.
Clin. Chem. 1997;43:2021-2038.
ABSTRACT | FULL TEXT  

Current Concepts in the Pharmacologic Treatment and Management of Tuberculosis
Gravatt
The Journal of School Nursing 1997;13:28-38.
ABSTRACT  

Tuberculosis among Health Care Workers
Menzies et al.
NEJM 1995;332:92-98.
FULL TEXT  

The Use of High-Efficiency Particulate Air-Filter Respirators to Protect Hospital Workers from Tuberculosis -- A Cost-Effectiveness Analysis
Adal et al.
NEJM 1994;331:169-173.
ABSTRACT | FULL TEXT  

The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular Methods
Small et al.
NEJM 1994;330:1703-1709.
ABSTRACT | FULL TEXT  

Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection
Small et al.
NEJM 1993;328:1137-1144.
ABSTRACT | FULL TEXT